Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-05-20
2008-08-26
Saoud, Christine J (Department: 1647)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023500, C435S069100, C435S069520, C435S069700, C435S320100, C424S085200
Reexamination Certificate
active
07417134
ABSTRACT:
The present invention provides a fusion polypeptide capable of binding interleukin-1 (O:-1) to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of using the fusion polypeptide.
REFERENCES:
patent: 5470952 (1995-11-01), Stahl et al.
patent: 6610750 (2003-08-01), Charbit et al.
patent: 0835939 (1991-06-01), None
patent: 0533006 (1992-09-01), None
patent: WO93/19163 (1993-09-01), None
patent: WO93/19777 (1993-10-01), None
patent: WO94/22914 (1994-10-01), None
patent: WO95/06737 (1995-03-01), None
patent: WO96/11213 (1996-04-01), None
patent: WO96/23881 (1996-08-01), None
patent: WO96/35783 (1996-11-01), None
patent: WO97/15669 (1997-05-01), None
patent: WO97/31946 (1997-09-01), None
patent: WO99/37772 (1999-07-01), None
Greenfeeder, S.A., et al., (1995) J. Biol. Chem. 270(23):13757-13765.
Seipelt, I., et al., (1997) Biochem. Biophys. Res. Comm. 293:534-542.
Stahl, N., et al., (1999) FASEB J. Abstract, 1457.
U.S. Appl. No. 60/101,858, filed Sep. 25, 1998, Stahl,N. & Yancopoulos,G.D.
U.S. Appl. No. 09/313,942, filed May 19, 1999, Stahl,N. & Yancopoulos,G.D.
J. of Biol. Chem., 1995, Greenfeeder, S.A., et. al., “Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex”, 270(23):13757-13765.
Biochem and Biophys Res Comm, 1997, Seipelt, I., et al., “Overexpression, Purification, and Use of a Soluble Human Interleukin-4 Receptor α-chain/Igγ1 Fusion Protein for Ligand Binding Studies,” 239:534-542.
FASEB Journal, 1999, Stahl,N., et al., “Cytokine Traps: Heteromeric Receptor-Based Protein Therapeutics that Function as High-Affinity Blockers of Cytokine Action,” Abstract, 1457.
Stahl Neil
Yancopoulos George D.
Gregg, Esq. Valeta
Regeneron Pharmaceuticals Inc.
Saoud Christine J
Seharaseyon Jegatheesan
LandOfFree
IL-1 receptor based cytokine traps and method of using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-1 receptor based cytokine traps and method of using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-1 receptor based cytokine traps and method of using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993512